DAVID PENDARVIS - 11 Nov 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Administrative Officer
Signature
David Pendarvis, Chief Administrative Officer
Issuer symbol
RMD
Transactions as of
11 Nov 2021
Net transactions value
-$302,007
Form type
4
Filing time
15 Nov 2021, 13:06:03 UTC
Previous filing
05 Nov 2021
Next filing
18 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Tax liability $401,919 -1,549 -1.3% $259.47 119,502 11 Nov 2021 Direct F1
transaction RMD ResMed Common Stock Options Exercise $99,912 +983 +0.82% $101.64 120,485 11 Nov 2021 Direct
transaction RMD ResMed Common Stock Gift $0 -10,000 -8.3% $0.000000 110,485 11 Nov 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -983 -5.1% $0.000000 18,468 11 Nov 2021 ResMed Common Stock 983 $101.64 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/14/2018, 11/21/2019 and 11/19/2020.
F2 Gift of shares to The San Diego Foundation, a 501(c)(3) nonprofit organization. Mr. Pendarvis has no beneficial interest, control or dispositive power over the gifted shares.
F3 Includes 64.3996 shares of ResMed stock purchased on October 29, 2021, through the ResMed Employee Stock Purchase Plan.
F4 Represents date options first became exercisable. Options vest 1/3 per year.